Role of Toll-like receptors 2 and 4 in the induction of cyclooxygenase-2 in vascular smooth muscle
- 8 March 2005
- journal article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 102 (12) , 4637-4642
- https://doi.org/10.1073/pnas.0407655101
Abstract
Bacteria stimulate macrophages as part of normal host defense. However, when this response is not limited, vascular smooth muscle may also be activated to express “vasoactive” genes (e.g., cyclooxygenase), leading to vascular collapse and septic shock. In macrophages, Toll-like receptors (TLRs) 4 and 2 transduce responses to Gram-negative and Gram-positive bacteria, respectively. However, the role of these TLRs in sensing bacteria in vascular smooth muscle is unclear. To address this question, we have cultured vascular smooth muscle cells from mice deficient in TLR4 (TLR4 –/– mice), mice deficient in TLR2 (TLR2 –/– mice), or control mice. Cells cultured from control or TLR2 –/– mice, but not from TLR4 –/– mice, expressed cyclooxygenase-2 and released increasing levels of prostaglandin E 2 after stimulation with whole Escherichia coli bacteria; the combination of IL-1β plus TNF-α induced cyclooxygenase-2 in cells cultured from all three groups of animals. By contrast, Staphylococcus aureus affected cyclooxygenase-2 expression in two distinct ways. First, S. aureus induced a transient inhibition of cyclooxygenase-2 expression, which was overcome with time, and increased protein expression was noted. The effects of S. aureus on cyclooxygenase-2 expression were TLR2- and not TLR4-dependent. Thus, we show that Gram-positive and Gram-negative bacteria induce cyclooxygenase-2 in vascular smooth muscle with differing temporal profiles but with appropriate TLR2-versus-TLR4 signaling. These data have important implications for our understanding of the innate immune response in vascular cells and how it may impact vascular disease.Keywords
This publication has 26 references indexed in Scilit:
- Toll-Like Receptor 4, But Not Toll-Like Receptor 2, Is a Signaling Receptor forEscherichiaandSalmonellaLipopolysaccharidesThe Journal of Immunology, 2000
- Toll-like receptors in the induction of the innate immune responseNature, 2000
- Expression of Cyclo-oxygenase-2 in Human Atherosclerotic Carotid ArteriesEuropean Journal of Vascular and Endovascular Surgery, 2000
- Cutting Edge: Repurification of Lipopolysaccharide Eliminates Signaling Through Both Human and Murine Toll-Like Receptor 2The Journal of Immunology, 2000
- Differential Roles of TLR2 and TLR4 in Recognition of Gram-Negative and Gram-Positive Bacterial Cell Wall ComponentsPublished by Elsevier ,1999
- Defective LPS Signaling in C3H/HeJ and C57BL/10ScCr Mice: Mutations in Tlr4 GeneScience, 1998
- Differential Induction of Cyclooxygenase-2 in Human Arterial and Venous Smooth MuscleArteriosclerosis, Thrombosis, and Vascular Biology, 1998
- Cytokine and Lipopolysaccharide Stimulation of Endothelin-1 Release from Human Internal Mammary Artery and Saphenous Vein Smooth-Muscle CellsJournal of Cardiovascular Pharmacology, 1998
- Characterization of the induction of nitric oxide synthase and cyclo‐oxygenase in rat aorta in organ cultureBritish Journal of Pharmacology, 1997
- Release of Isoprostanes by Human Pulmonary Artery in Organ Culture: A Cyclo-oxygenase and Nitric Oxide Dependent PathwayBiochemical and Biophysical Research Communications, 1997